ESEric Michael Smith

Eric Michael Smith

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eric Michael Smith has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Ashley E. Kita

    Department of Head and Neck Surgery David Geffen School of Medicine University of California Los Angeles California USA

    5 shared publications
  • Joseph C. Wu

    Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA; Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, CA, USA

    2 shared publications
  • Kari C. Nadeau

    Sean N. Parker Center for Allergy and Asthma Research and the Division of Pulmonary, Allergy & Critical Care Medicine, Department of Medicine, Stanford University, Stanford, CA, USA

    2 shared publications
  • Amin Mirzaaghasi

    Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA

    1 shared publication
  • Anja Heider

    Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland

    1 shared publication
  • Anushka Shah

    Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto, CA

    1 shared publication

Latest Publications

  • Open Access

    A novel inhaled anesthesia technique for concurrent direct laryngoscopy in rats

    by Corinne Negvesky, Amin Mirzaaghasi, Eric M. Smith, Ashley E. Kita

    The current anesthetic standard for laryngoscopy in rats utilizes injectable intraperitoneal anesthesia. Injectable anesthesia is suboptimal for short procedures due to variability in anesthesia duration and anesthetic side effects. Conversely, inhalational gas anesthesia offers precise titration with a rapid onset and offset. However, its use during laryngoscopy has not been documented due to existing administration techniques obstructing direct visualization of the larynx. The technique described here allows real‐time visualization of the rat larynx with concurrent administration of inhaled anesthetic gas. This method is particularly well‐suited for recurrent laryngeal nerve or vocal fold pathology studies, where repeat visualization of the larynx is necessary.

  • Open Access

    Transtympanic Injection of Antioxidant‐Eluting Microparticles for Otoprotection From Cisplatin Toxicity in a Mouse Model

    by Eric Michael Smith, Carmen Boixo, Larry Hoffman, Ashley E. Kita

    Objective: Cisplatin is a chemotherapeutic agent with the undesirable side effect of ototoxicity. Transtympanic injections of antioxidant formulations may provide local otoprotection. We tested a novel antioxidant‐eluting microparticle for its otoprotective capability from systemic cisplatin as measured by cochlear electrophysiology. Study Design: Basic science. Setting: Translational research laboratory. Methods: Eighteen mice were assigned to three groups. All mice underwent baseline click‐evoked auditory brainstem response (ABR) audiometry and right ear microparticle injections before beginning 42‐day intraperitoneal administration regimens of either saline (healthy control empty microparticle [HCEMP] group) or cisplatin (cisplatin empty microparticle [CEMP] group and cisplatin N ‐acetylcysteine microparticle [CNAC] group). These regimens consisted of three 4‐day cycles of intraperitoneal saline or cisplatin administration followed by 10 rest days. HCEMP and CEMP received right‐sided transtympanic empty microparticles, and CNAC received transtympanic N ‐acetylcysteine eluting microparticles. On day 43, all mice underwent posttreatment ABR. ABR thresholds and threshold shifts were analyzed with mixed‐effects models and Tukey's post hoc tests and were compared across pretreatment/posttreatment ears, treatment groups, and injected and non‐injected ears. Results: We found that threshold shifts in the ears that received a transtympanic injection of N ‐acetylcysteine and three cycles of intraperitoneal cisplatin were similar to the paired ears of mice that received no cisplatin. Mice that received a transtympanic injection without N ‐acetylcysteine and intraperitoneal cisplatin had increased thresholds compared to mice that received a transtympanic injection of N ‐acetylcysteine and cisplatin. Conclusion: Transtympanic N ‐acetylcysteine microparticle injections provided functional otoprotection in cisplatin‐exposed mice.

  • Open Access

    Identification of a Musculus Levator Claviculae on Physical Exam: A Case Report and Literature Review

    by Eric Smith, Erik Vanstrum, Ashley Kita

    Background and Clinical Significance: The levator claviculae muscle (also known as cleidocervicalis) is a vestigial muscle located in the posterior triangle of the neck, extending from the upper cervical transverse processus to the clavicle. It has been detected in ~2% of humans, but is rarely documented in the radiologic or anatomic literature. When found on physical exam, it is usually mis-identified as lymphadenopathy, metastasis, cysts, an aneurysm, or other masses. It has been implicated in a few cases of thoracic outlet syndrome. Case Presentation: Herein, we describe a 25-year-old man with a weightlifting history, who was found to have a right levator claviculae muscle in the setting of unilateral mixed neurovascular thoracic outlet syndrome. The patient presented with right-sided extremity paresthesias, pain in the neck, shoulder, and arm, and symptom exacerbation with overhead activities. He also described intermittent unilateral pulsatile tinnitus during strenuous exercise. On physical exam, he was found to have a right carotid bruit, unequal systolic blood pressures, and positive Roos and Adson’s testing. The variant muscle was identified with a modified exam maneuver, and was further characterized with sonography and MRI. Symptoms were managed with activity restriction and NSAIDs. We reviewed 17 cases of levator claviculae variant muscles in patients. Conclusions: The presence of levator claviculae muscles has been detected in patients with thoracic outlet syndrome, but never in a patient with an audible bruit and pulsatile tinnitus. This physical exam maneuver, used in conjunction with multimodal imaging, successfully aided diagnosis and direct medical management in this case.

  • Open Access

    Validating a Novel 3D Printed Depth Gauge With Mandible Models

    by Eric M. Smith, Rhorie P. Kerr, Ashley E. Kita

    Background/need: Traditional bone depth gauges are notoriously inaccurate tools, often used in head and neck surgery, that estimate the screw length needed for fracture fixation after bicortical drilling. Complications related to inaccurately sized screws may include soft tissue irritation or weakness of the repair and subsequent refracture. To improve size selection accuracy, a prototype depth gauge was 3D printed and tested in mandibles. Methods: The prototype was constructed with a rotating deployable hook and intra-operative disassembly feature to extract the device if it became stuck. Ten 3.2 mm holes were drilled in a synthetic mandible, and 12 medical students, 12 residents, and 6 fellows/attendings measured them with industry standard and prototype depth gauges. User measurements from the prototype were compared to the holes’ true depths and accuracy for each device was based on a user’s closeness to the true depths. Differences between devices and training levels were analyzed with paired t tests and two-way ANOVAs. The device was also tested by 2 attendings in 2 cadavers with 8 holes drilled in each mandible. Results: In the synthetic model, differences between true depths and measured depths for the 2 gauges were not significantly different. Total accuracy was greater with the prototype, along with increased medical student accuracy compared to the industry standard. Prototype malfunctions were noted in the cadaveric model with no significant differences in device accuracy. Conclusion: A novel 3D-printed depth gauge was tested and found to improve first time user accuracy and perform non-inferiorly to an industry standard depth gauge.


  • Open Access

    Allergic fungal sinusitis mimicking mycetoma: A diagnostic challenge

    by Eric M. Smith, Steven D. Hart, Ashley E. Kita


  • Adverse effects of air pollution‐derived fine particulate matter on cardiovascular homeostasis and disease

    by Hye Ryeong Bae, Mark Chandy, Juan Aguilera, Eric M. Smith, Kari C. Nadeau, Joseph C. Wu, David T. Paik


  • Understanding the Association of IgE and Gut and Mucosal Proteins in Atopic Disorders

    by Anushka Shah, Ella Parsons, Eric Smith, Laurie Kost, Ismail Ögülür, Anja Heider, Ge Tan, Robert Hamilton, Sayantani Sindher, Fang Liu, et al.

  • Open Access

    Cumulative Lifetime Burden of Cardiovascular Disease From Early Exposure to Air Pollution

    by Juyong Brian Kim, Mary Prunicki, Francois Haddad, Christopher Dant, Vanitha Sampath, Rushali Patel, Eric Smith, Cezmi Akdis, John Balmes, Michael P. Snyder, et al.

    The disease burden associated with air pollution continues to grow. The World Health Organization (WHO) estimates ≈7 million people worldwide die yearly from exposure to polluted air, half of which—3.3 million—are attributable to cardiovascular disease (CVD), greater than from major modifiable CVD risks including smoking, hypertension, hyperlipidemia, and diabetes mellitus. This serious and growing health threat is attributed to increasing urbanization of the world's populations with consequent exposure to polluted air. Especially vulnerable are the elderly, patients with pre‐existing CVD, and children. The cumulative lifetime burden in children is particularly of concern because their rapidly developing cardiopulmonary systems are more susceptible to damage and they spend more time outdoors and therefore inhale more pollutants. World Health Organization estimates that 93% of the world's children aged <15 years—1.8 billion children—breathe air that puts their health and development at risk. Here, we present growing scientific evidence, including from our own group, that chronic exposure to air pollution early in life is directly linked to development of major CVD risks, including obesity, hypertension, and metabolic disorders. In this review, we surveyed the literature for current knowledge of how pollution exposure early in life adversely impacts cardiovascular phenotypes, and lay the foundation for early intervention and other strategies that can help prevent this damage. We also discuss the need for better guidelines and additional research to validate exposure metrics and interventions that will ultimately help healthcare providers reduce the growing burden of CVD from pollution.